General Information of the Compound
Compound ID |
CP0179372
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole
Show/Hide
|
||||||||||||||||||
Synonyms |
1,4,5,6-Tetrahydro-3-(1H-tetrazol-5-yl)cyclopenta[c]pyrazole
1,4,5,6-tetrahydro-3-(2H-tetrazol-5-yl)Cyclopentapyrazole
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole
3-(2H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole
3-(2H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole
4U62D8JYIQ
851776-28-8
AKOS030526928
BCP18112
BDBM50273099
CHEMBL456145
CS-4589
GTPL5784
LTQYSJKGRPGMPO-UHFFFAOYSA-N
MK 0354
MK-0354
MolPort-009-683-033
SCHEMBL1875705
UNII-4U62D8JYIQ
ZINC38312374
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C7H8N6
|
||||||||||||||||||
Molecular Weight |
176.183
|
||||||||||||||||||
Canonical SMILES |
C1Cc2[nH]nc(c2C1)-c1nnn[nH]1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C7H8N6/c1-2-4-5(3-1)8-9-6(4)7-10-12-13-11-7/h1-3H2,(H,8,9)(H,10,11,12,13)
Show/Hide
|
||||||||||||||||||
InChIKey |
LTQYSJKGRPGMPO-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound